NEWTON (PTC) Ltd

13F Holdings History for Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 (LYEL)

Symbol: LYEL on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001
Latest Disclosed Ownership: 755K shares
Security Ownership: 3.93%

Newton (PTC) Limited ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)

2025-11-12 - Newton (PTC) Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 755K shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL). This represents 3.93% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Newton (PTC) Limited	3.93%		$12.3M	755K			$16.24	13G/A	9/30/2025	12 Nov 2025 16:57:35